| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2004 | EP1435899A1 A composition for promoting hair growth |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435874A1 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1435786A1 Pesticidal formulations |
| 07/14/2004 | EP1435782A1 Treatment for cystic fibrosis |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1263429B1 Antiviral therapy |
| 07/14/2004 | EP1254120B1 Use of pyrimidine endothelin antagonists in companion animals |
| 07/14/2004 | EP1248776B1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1202996B9 Titanium derived compounds, preparation and use thereof |
| 07/14/2004 | EP1196170B1 Use of a macrolide compound for the manufacture of a medicament for the treatment of brain damage caused by ischemia or hemorrhage |
| 07/14/2004 | EP1173186A4 Use of tagatose to enhance key blood factors |
| 07/14/2004 | EP1171105B1 Transdermal therapeutic system with a highly effective neuroleptic agent |
| 07/14/2004 | EP1169326B1 Process for preparing alendronic acid |
| 07/14/2004 | EP1169026B1 Use of ap-1 activators to treat glaucoma and ocular hypertension |
| 07/14/2004 | EP1150667B1 Cyclohexenone long-chain alcohol for treating amyotrophic lateral sclerosis |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1140102B1 Triazineone compounds for treating diseases due to neospora and toxoplasma |
| 07/14/2004 | EP1123104B1 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 07/14/2004 | EP1117373B1 Hair tonic |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | EP1071394B1 Use of unsymmetrically substituted triazine derivatives in cosmetic or dermatological preparations for maintaining the urocanic acid status of the skin |
| 07/14/2004 | EP1051973B1 Optic papillary circulation improving agents |
| 07/14/2004 | EP1047426A4 Use of methylnaltrexone and related compounds |
| 07/14/2004 | EP1045692B1 Skin protection composition |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP1014986B1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST |
| 07/14/2004 | EP1002792B1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 07/14/2004 | EP0984774B1 Gastroretentive controlled release microspheres for improved drug delivery |
| 07/14/2004 | EP0983248B1 Analogs of duocarmycin and cc-1065 |
| 07/14/2004 | EP0976754B1 Remedies/preventives for respiratory diseases |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0934325B1 Mycophenolic bisphosphonate compounds |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | EP0871615B1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/14/2004 | EP0723443B1 Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1512995A Novel ligand for nicotinic acety/choline receptors useful in therapy |
| 07/14/2004 | CN1512994A Water soluble porphyri nderivatives for photodynamic therapy, their use and manufacture |
| 07/14/2004 | CN1512993A Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512900A Aerosol forming device for use in inhalation therapy |
| 07/14/2004 | CN1512893A Use of antioxidant for treating and/or preventing surface ocular disorders |
| 07/14/2004 | CN1512889A Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite |
| 07/14/2004 | CN1512887A Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 07/14/2004 | CN1512886A Use of antiprogestins for prophylaxis and treatment or hormone-dependent diseases |
| 07/14/2004 | CN1512885A Pharmaceutical combinations |
| 07/14/2004 | CN1512884A 阿立哌唑口服溶液 Aripiprazole Oral Solution |
| 07/14/2004 | CN1512883A Crf受体拮抗剂 Crf receptor antagonist |
| 07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
| 07/14/2004 | CN1512881A Photosensitive and method for production thereof |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1512879A Novel arylaminopropane analogues and their use for treatment of glaucoma |
| 07/14/2004 | CN1512878A Lipolysis accelerator, cosmetic skin preparation and food or beverage composition each containing the same, and method for reducing body weight and use |
| 07/14/2004 | CN1512877A Method for encapsulating active substance |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1512875A Inhalation capsules |
| 07/14/2004 | CN1512845A Calorically dense liquid oral supplement |
| 07/14/2004 | CN1511942A Red rice mould mutant strain and its use in preparing fermented product with blood pressure reducing activity |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1511840A Puerarin compound containing water soluble group and its preparation and use |
| 07/14/2004 | CN1511838A Triptolide alcohol derivative and its use |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511835A Benzo-isoselenazole derivatives having anti inflammation, anti-tumor and anti-thrumbosis function and its use |
| 07/14/2004 | CN1511834A Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives |
| 07/14/2004 | CN1511833A Process for preparing isoxazolyl alkyl diketone compound |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511828A Sufonic aniline derivatives and their medicinal use |
| 07/14/2004 | CN1511820A Novel intemediate for preparing 4-hydroxy-2-oxygen-pyran derivatives as protease inhibitor |
| 07/14/2004 | CN1511589A Biological compactable medicine carrier and its preparing method |
| 07/14/2004 | CN1511549A Composition containing scutellaria root for anti-tumor, anti-inflammation and tumor preventing medicine |
| 07/14/2004 | CN1511542A Composition for improving obstacle under pharynx |
| 07/14/2004 | CN1511540A Use of scutellarin in preparing medicine for treating or preventing stomatocace |
| 07/14/2004 | CN1511539A Dogwood fruit extract and its preparing method and use |
| 07/14/2004 | CN1511538A Use of scutellarin in inhibiting vascularization |
| 07/14/2004 | CN1511537A Novel use of daidzein or isoflavones or pueraria flavonid |
| 07/14/2004 | CN1511536A Use of kutkoside-II in nerve cell injury protection |
| 07/14/2004 | CN1511535A Use of spirosterol type steroid saponin in preparing medicine for treating cardio-cerebral vascular disease |
| 07/14/2004 | CN1511534A Total sanchinoside and ferulic acid composition for treating cardio-cerebral vascular disease and diabetes and its use |
| 07/14/2004 | CN1511533A Use of bufadienolide in inhibiting vascularization |
| 07/14/2004 | CN1511532A Medical composition |
| 07/14/2004 | CN1511531A Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 07/14/2004 | CN1511530A Use of ligustrazine in preparing medicine for treating penis erection dysfunction |
| 07/14/2004 | CN1511529A Medicine for treating cerebrovascular desease |
| 07/14/2004 | CN1511528A Use of fangchinoline in vascularization inhibiting medicine |